financetom
Business
financetom
/
Business
/
PNE says sale prospects unclear as bids trail market valuation (Aug 10)
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PNE says sale prospects unclear as bids trail market valuation (Aug 10)
Aug 12, 2026 11:23 PM

Aug 10 (Reuters) - German renewable project developer PNE

on Monday said that interest received so far in its

sale process indicated potential buyers were unwilling to match

its market valuation, casting doubts on whether a transaction

would materialise.

A sale of the company could fetch more than €1 billion

($1.15 billion), Reuters reported in June.

* PNE, which has a market capitalization of €757.61 million,

is 50.06% owned by a fund managed by Morgan Stanley

Infrastructure Partners, according to LSEG data.

* "It is currently uncertain whether a transaction will

materialise and what its terms would be," PNE said.

* The development comes as the Morgan Stanley Infrastructure

Partners fund seeks to cash in on the PNE stake after a previous

sale effort ended without success.

* Reuters reported last year that Morgan Stanley ( MS ) was working

with Goldman Sachs ( GS ) to explore a sale. Other shareholders

were also prepared to sell, sources have said.

* PNE has a 21.7-gigawatt pipeline of wind and solar

projects, with more than half in core markets Germany, France

and Poland.

* Multiple companies have eyed PNE in the past, including

Switzerland's Partners Group and Canada's CPPIB,

Reuters reported.

($1 = 0.8663 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
U.S. FDA approves ImmunityBio's bladder cancer therapy
U.S. FDA approves ImmunityBio's bladder cancer therapy
Apr 22, 2024
April 22 (Reuters) - The U.S. FDA approved ImmunityBio's ( IBRX ) combination therapy to treat a type of bladder cancer, the regulator said on Monday, which would help bring the company's first product to market. ...
Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire
Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire
Apr 22, 2024
06:00 PM EDT, 04/22/2024 (MT Newswires) -- Clearwater Analytics ( CWAN ) said Monday it completed the acquisition of risk and performance analytics products from Wilshire Advisors. Wilshire Axiom, Wilshire Atlas, Wilshire Abacus and Wilshire iQComposite will be integrated with Clearwater's offerings. Clearwater previously said the assets will cost $40 million and add about $7 million in annualized revenue. ...
ADM CFO to resign as company faces US government investigation
ADM CFO to resign as company faces US government investigation
Apr 22, 2024
(Reuters) - Grain trader Archer-Daniels-Midland ( ADM ) said on Monday that Chief Financial Officer Vikram Luthar will resign from his role effective Sept. 30. Luthar is the highest-level executive to leave the firm since it disclosed accounting issues within its Nutrition division that later triggered two government investigations and forced it to revise six years of financial data. ADM...
Copper output at Chile's Codelco set to rise this year, CESCO says
Copper output at Chile's Codelco set to rise this year, CESCO says
Apr 22, 2024
SANTIAGO (Reuters) - Chile's state-run copper miner Codelco is poised to improve production this year and begin to climb from its lowest dip in a quarter century, the head of Chilean copper studies center CESCO said ahead of a major industry conference that starts Monday. Codelco is aiming to produce between 1.325 million and 1.390 million metric tons of copper...
Copyright 2023-2026 - www.financetom.com All Rights Reserved